Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Pulse Biosciences Inc PLSE

Healthcare Medical Devices
Pulse Biosciences, Inc. is a bioelectric medicine company. The Company’s proprietary CellFX nsPFA technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. The Company is engaged in the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation and in a select few other markets where it... see more

Recent & Breaking News (NDAQ:PLSE)

Pulse Biosciences Grants Equity Incentive Awards to New Employees

Business Wire March 15, 2019

Pulse Biosciences Announces Late Breaking Oral Presentation of Sebaceous Hyperplasia Study Results at the 2019 AAD Annual Meeting

Business Wire March 1, 2019

Pulse Biosciences Submits 510(K) to U.S. FDA for CellFX™ System

Business Wire February 28, 2019

Pulse Biosciences Grants Equity Incentive Awards to New Employees

Business Wire February 15, 2019

Pulse Biosciences Quarterly Investor Conference Call

Business Wire February 7, 2019

Pulse Biosciences to Report Fourth Quarter and Full Year 2018 Operational Highlights and Financial Results

Business Wire January 28, 2019

Pulse Biosciences Announces Two Appointments Focused on CellFX™ Commercialization: Promotion of Edward Ebbers and Addition of Robert Tyson

Business Wire January 17, 2019

Pulse Biosciences Grants Equity Incentive Awards to New Employees

Business Wire January 15, 2019

Pulse Biosciences Announces Positive Clinical Results of Its Nano-Pulse Stimulation™ Technology Platform to Treat Patients with Sebaceous Hyperplasia Lesions on the Face

Business Wire January 7, 2019

Pulse Biosciences Grants Equity Incentive Awards to New Employees

Business Wire December 17, 2018

Pulse Biosciences, Inc. Announces Closing of Its $45 Million Rights Offering

Business Wire December 14, 2018

Investor Expectations to Drive Momentum within eBay, Pulse Biosciences, Evolus, Weibo, OptiNose, and The Descartes Systems Group — Discovering Underlying Factors of Influence

GlobeNewswire December 11, 2018

Pulse Biosciences, Inc. Announces Oversubscription, Pricing and Preliminary Results for Its $45 Million Rights Offering

Business Wire December 7, 2018

Pulse Biosciences, Inc. Announces Commencement of Rights Offering

Business Wire November 19, 2018

Pulse Biosciences Grants Equity Incentive Awards to New Employees

Business Wire November 15, 2018

Pulse Biosciences, Inc. Announces Record Date, Subscription Pricing, and Expiration Date for Rights Offering and Effectiveness of Its Registration Statement

Business Wire November 7, 2018

Report: Developing Opportunities within Pulse Biosciences, Baxter International, FirstEnergy, Affiliated Managers Group, Baidu, and Shopify — Future Expectations, Projections Moving into 2018

GlobeNewswire November 2, 2018

Pulse Biosciences Quarterly Investor Conference Call

Business Wire October 30, 2018

Pulse Biosciences Files Registration Statement for Rights Offering

Business Wire October 25, 2018

Pulse Biosciences to Report Third Quarter 2018 and Operational Highlights and Financial Results

Business Wire October 23, 2018